ClinicalTrials.gov
public full text
Public Domain
A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart Failure
This study is a single-center, randomized, double-blind, placebo-controlled study in patients with stable heart failure to evaluate the safety, tolerability, pharmacokinetics, and efficacy of multiple ascending doses of Bendavia™ (MTP-131) intravenous infusion.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Impact of the Pharmaceutical Care on the Quality of Life in Patients With Chagas Heart Disease#850036
- Study to Evaluate the Effects of TRV120027 in Patients With Heart Failure#967383
- Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure#1033384
- Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients#824879
- Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.#904629
Record · ID 911831
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive